These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37702402)

  • 1. High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.
    Gupta S; Wells SL; Jose AM; Seitter RH; Feghali L; Devaraj N; Hartigan PM; Yacoubian S; Kwiatkowski DJ; Burke DM; Barlow J; Bueno R; Leaf DE
    J Surg Oncol; 2023 Dec; 128(7):1141-1149. PubMed ID: 37702402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preloading magnesium attenuates cisplatin-associated nephrotoxicity: pilot randomized controlled trial (PRAGMATIC study).
    Suppadungsuk S; Phitakwatchara W; Reungwetwattana T; Pathumarak A; Phakdeekitcharoen B; Kitiyakara C; Srisuwarn P; Davenport A; Nongnuch A
    ESMO Open; 2022 Feb; 7(1):100351. PubMed ID: 34953401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
    Hod T; Freedberg KJ; Motwani SS; Chen M; Frendl G; Leaf DE; Gupta S; Mothi SS; Richards WG; Bueno R; Waikar SS
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1510-1518. PubMed ID: 32631662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M; Abdollahi A; Ghahremani MH
    Phytother Res; 2015 Jul; 29(7):1046-53. PubMed ID: 25857366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.
    Solanki MH; Chatterjee PK; Gupta M; Xue X; Plagov A; Metz MH; Mintz R; Singhal PC; Metz CN
    Am J Physiol Renal Physiol; 2014 Aug; 307(4):F369-84. PubMed ID: 24944268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma.
    Okubo K; Ishibashi H; Wakejima R; Baba S; Asakawa A; Seshima H
    JTCVS Open; 2023 Dec; 16():977-986. PubMed ID: 38204668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
    Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
    Nowak AK; Lesterhuis WJ; Kok PS; Brown C; Hughes BG; Karikios DJ; John T; Kao SC; Leslie C; Cook AM; Pavlakis N; Briscoe K; O'Byrne KJ; Karapetis CS; Lam WS; Langford A; Yip S; Stockler MR
    Lancet Oncol; 2020 Sep; 21(9):1213-1223. PubMed ID: 32888453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Kidney Injury Following Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.
    Chen KL; Shamavonian R; Karpes JB; Alzahrani NA; Morris DL
    Anticancer Res; 2021 Mar; 41(3):1641-1646. PubMed ID: 33788760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.
    Burt BM; Richards WG; Lee HS; Bartel S; Dasilva MC; Gill RR; Jaklitsch MT; Johnson BE; Swanson SJ; Bueno R; Sugarbaker DJ
    J Thorac Oncol; 2018 Sep; 13(9):1400-1409. PubMed ID: 29753120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
    Arrieta O; López-Macías D; Mendoza-García VO; Bacon-Fonseca L; Muñoz-Montaño W; Macedo-Pérez EO; Muñiz-Hernández S; Blake-Cerda M; Corona-Cruz JF
    Cancer Chemother Pharmacol; 2014 May; 73(5):975-82. PubMed ID: 24687408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile.
    Nakano T; Chahinian AP; Shinjo M; Togawa N; Tonomura A; Miyake M; Ninomiya K; Yamamoto T; Higashino K
    Cancer; 1999 Jun; 85(11):2375-84. PubMed ID: 10357408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.
    Mense ES; Smit AAJ; Crul M; Franssen EJF
    J Clin Pharm Ther; 2019 Apr; 44(2):249-257. PubMed ID: 30578577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
    Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
    PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.
    Hase T; Miyazaki M; Ichikawa K; Yogo N; Ozawa N; Hatta T; Ando M; Sato M; Kondo M; Yamada K; Hasegawa Y
    Int J Clin Oncol; 2020 Nov; 25(11):1928-1935. PubMed ID: 32740717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.
    Groth SS; Ripley RT
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1519-1520. PubMed ID: 32771233
    [No Abstract]   [Full Text] [Related]  

  • 18. Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice.
    Solanki MH; Chatterjee PK; Xue X; Gupta M; Rosales I; Yeboah MM; Kohn N; Metz CN
    Am J Physiol Renal Physiol; 2015 Jul; 309(1):F35-47. PubMed ID: 25947343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery.
    Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T
    Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study.
    Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P
    Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.